This website uses frames, please update your browser.
Gelclair has a mechanical action which provides pain relief by adhering to the mucosal surface of the mouth, soothing mouth lesions caused by medication, disease, radiotherapy, chemotherapy, irritation due to oral surgery, ageing and traumatic ulcers caused by braces and ill-fitting dentures. Gelclair is also indicated for diffuse aphthous ulcers.
Patients with oral lesions - in particular mucositis due to treatment with chemotherapy or radiotherapy - tend to be debilitated and in poor general health. The pain and discomfort associated with oral mucositis may well interfere with the ability to eat and drink, and sometimes patients need artificial feeding to help them through this difficult period. Anything offering rapid, symptomatic relief, which would also help patients to eat and drink more easily, is much needed.
Gelclair has been developed to meet these requirements. It contains the barrier-forming ingredients polyvinylpyrrolidone (PVP) and sodium hyaluronate, which form a thin adhesive layer over the oral mucosa when Gelclair is rinsed within the mouth. This barrier shields exposed or sensitised nerve endings from overstimulation during eating, drinking, speaking or even at rest. Gelclair has been shown to reduce pain and help patients to eat and drink more easily. (see 'supporting data' for more information)